Found: 30
Select item for more details and to access through your institution.
MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 3, p. 431, doi. 10.1007/s00432-017-2562-8
- By:
- Publication type:
- Article
Analysis of adverse drug reactions of Osimertinib in the 2nd‐line treatment of EGFR mutant advanced nonsmall cell lung cancer.
- Published in:
- Precision Medical Sciences, 2022, v. 11, n. 2, p. 69, doi. 10.1002/prm2.12075
- By:
- Publication type:
- Article
Prolonged survival in advanced squamous cell lung carcinoma by rational and standardized treatment: A case report of long‐term survival in a patient with NSCLC.
- Published in:
- Precision Medical Sciences, 2021, v. 10, n. 1, p. 33, doi. 10.1002/prm2.12035
- By:
- Publication type:
- Article
Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36491-3
- By:
- Publication type:
- Article
Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1377858
- By:
- Publication type:
- Article
Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1206768
- By:
- Publication type:
- Article
Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1206768
- By:
- Publication type:
- Article
Immunotherapy for bilateral multiple ground glass opacities: An exploratory study for synchronous multiple primary lung cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1009621
- By:
- Publication type:
- Article
Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 209, doi. 10.1007/s10637-021-01163-w
- By:
- Publication type:
- Article
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 315, doi. 10.1007/s10637-017-0536-y
- By:
- Publication type:
- Article
Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 269, doi. 10.1007/s10637-017-0506-4
- By:
- Publication type:
- Article
Clinical evaluation of plasma coagulation parameters in patients with advanced‐stage non‐small cell lung cancer treated with palliative chemotherapy in China.
- Published in:
- International Journal of Clinical Practice, 2020, v. 74, n. 12, p. 1, doi. 10.1111/ijcp.13619
- By:
- Publication type:
- Article
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non--Small-Cell Lung Cancer (NSCLC).
- Published in:
- Clinical Lung Cancer, 2016, v. 17, n. 2, p. 119, doi. 10.1016/j.cllc.2015.12.002
- By:
- Publication type:
- Article
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Co-Occurring EGFR S645C and EGFR L858R in a Patient with Lung Adenocarcinoma Induced Primary Resistance to Osimertinib.
- Published in:
- Lung Cancer: Targets & Therapy, 2023, v. 14, p. 79, doi. 10.2147/LCTT.S431252
- By:
- Publication type:
- Article
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
- Published in:
- International Journal of Nanomedicine, 2017, v. 12, p. 3721, doi. 10.2147/IJN.S131516
- By:
- Publication type:
- Article
3D-QSAR and Molecular Docking Studies of Novel GPR52 Agonists.
- Published in:
- Journal of Computational Biophysics & Chemistry, 2023, v. 22, n. 5, p. 615, doi. 10.1142/S2737416523500308
- By:
- Publication type:
- Article
Design of an Adaptive Height Control System for Sugarcane Harvester Header.
- Published in:
- Agronomy, 2024, v. 14, n. 8, p. 1644, doi. 10.3390/agronomy14081644
- By:
- Publication type:
- Article
Association analysis of GmMAPKs and functional characterization of GmMMK1 to salt stress response in soybean.
- Published in:
- Physiologia Plantarum, 2021, v. 173, n. 4, p. 2026, doi. 10.1111/ppl.13549
- By:
- Publication type:
- Article
Multicenter study of diagnostic procedures, genetic aberration analysis, and first‐line treatment of lung cancer in Jiangsu Province, China.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 3, p. 376, doi. 10.1111/1759-7714.12588
- By:
- Publication type:
- Article
Benmelstobart plus anlotinib in patients with EGFR-positive advanced NSCLC after failure of EGFR TKIs therapy: a phase I/II study.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01982-2
- By:
- Publication type:
- Article
Improving the Lung Cancer Clinical Trial Development by Incorporating Competing Risk Factors.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/2477285
- By:
- Publication type:
- Article
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 1, p. 1, doi. 10.1007/s11523-021-00859-6
- By:
- Publication type:
- Article
Supercapacitor‐based coordinated synthetic inertia scheme for voltage source converter‐based HVDC integrated offshore wind farm.
- Published in:
- IET Energy Systems Integration, 2024, v. 6, n. 1, p. 5, doi. 10.1049/esi2.12137
- By:
- Publication type:
- Article
Evaluation of plasma microRNA levels to predict insensitivity of patients with advanced lung adenocarcinomas to pemetrexed and platinum.
- Published in:
- Oncology Letters, 2016, v. 12, n. 6, p. 4829, doi. 10.3892/ol.2016.5295
- By:
- Publication type:
- Article
Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: A double-blind randomized controlled trial.
- Published in:
- Molecular Nutrition & Food Research, 2016, v. 60, n. 10, p. 2176, doi. 10.1002/mnfr.201600230
- By:
- Publication type:
- Article
Correction to: Study on synergistic catalytic degradation of wastewater containing polyacrylamide catalyzed by low‑temperature plasma‑H<sub>2</sub>O<sub>2</sub>.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Study on synergistic catalytic degradation of wastewater containing polyacrylamide catalyzed by low-temperature plasma-H<sub>2</sub>O<sub>2</sub>.
- Published in:
- Environmental Science & Pollution Research, 2023, v. 30, n. 52, p. 112206, doi. 10.1007/s11356-023-30287-0
- By:
- Publication type:
- Article
Clinical Significance of Disulfidptosis-related Genes and Functional Analysis in Gastric Cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 4, p. 1053, doi. 10.7150/jca.91796
- By:
- Publication type:
- Article
n-3 Polyunsaturated Fatty Acids and Metabolic Syndrome Risk: A Meta-Analysis.
- Published in:
- Nutrients, 2017, v. 9, n. 7, p. 703, doi. 10.3390/nu9070703
- By:
- Publication type:
- Article